https://limr.mainlinehealth.org/limr-search-results2026-01-27T13:39:42-05:00https://limr.mainlinehealth.org/about2025-01-31T11:12:54-05:00https://limr.mainlinehealth.org/our-researchers2024-02-06T12:07:36-05:00https://limr.mainlinehealth.org/programs2024-03-04T13:20:16-05:00https://limr.mainlinehealth.org/technology-development-licensing2023-11-17T14:57:27-05:00https://limr.mainlinehealth.org/about/leadership2025-01-15T16:32:25-05:00https://limr.mainlinehealth.org/about/our-history-and-accomplishments2024-03-04T13:21:10-05:00https://limr.mainlinehealth.org/about/milestones2025-05-29T14:46:48-04:00https://limr.mainlinehealth.org/about/our-location2023-11-07T16:18:30-05:00https://limr.mainlinehealth.org/about/endowed-chairs2023-11-07T15:54:39-05:00https://limr.mainlinehealth.org/about/catalyst-magazine2024-01-04T10:21:38-05:00https://limr.mainlinehealth.org/about/contact-us2024-09-25T12:29:15-04:00https://limr.mainlinehealth.org/our-researchers/publications2026-02-27T09:18:27-05:00https://limr.mainlinehealth.org/programs/cancer2025-05-14T10:51:21-04:00https://limr.mainlinehealth.org/programs/cardiovascular-disease2023-11-17T14:34:10-05:00https://limr.mainlinehealth.org/programs/clinical-research-center2025-07-17T12:26:34-04:00https://limr.mainlinehealth.org/programs/research-for-other-diseases-or-conditions2024-03-04T13:29:45-05:00https://limr.mainlinehealth.org/programs/services2023-11-17T14:35:01-05:00https://limr.mainlinehealth.org/programs/services/sars-cov-2-resource2025-05-29T12:04:34-04:00https://limr.mainlinehealth.org/programs/services/basic-and-preclinical-research-services2023-11-17T14:56:45-05:00https://limr.mainlinehealth.org/programs/services/center-for-human-antibody-technology2023-11-17T14:56:48-05:00https://limr.mainlinehealth.org/programs/services/limr-chemical-genomics-center2023-11-17T14:56:52-05:00https://limr.mainlinehealth.org/programs/services/wedge-prep-assessment-of-drug-candidates-qt-liability2023-11-17T14:56:56-05:00https://limr.mainlinehealth.org/technology-development-licensing/acapreneurial2023-12-11T16:29:22-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology2025-08-08T14:07:18-04:00https://limr.mainlinehealth.org/technology-development-licensing/biotech-incubator2023-11-17T15:07:56-05:00https://limr.mainlinehealth.org/technology-development-licensing/lankenau-ventures2024-11-12T09:35:06-05:00https://limr.mainlinehealth.org/technology-development-licensing/acapreneurial/incubator-success-stories2023-11-17T15:00:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/rapid-antigen-diagnostic-antibody-for-differentiating-sars-cov-2-variants-of-concern2023-12-21T11:56:11-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/targeted-nano-carrier-therapeutics-for-drug-resistant-cancers2023-12-21T11:56:11-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/small-molecule-inhibitors-and-poisons-of-polyamine-transport2023-12-21T11:56:11-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/new-uses-of-ido-inhibitors2023-12-21T11:56:11-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-bin1-antibodies-to-treat-ad2024-08-21T11:35:01-04:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-rhob-antibodies-for-retinopathy2023-12-21T11:56:11-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/blood-test-to-predict-delayed-nausea2023-12-21T11:56:12-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/healdot2023-12-21T11:56:16-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/healsuture2023-12-21T11:56:16-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/rhob-and-ckd2023-12-21T11:56:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/boursiquot-labial-retractor2025-03-26T13:43:02-04:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/toileting-privacy-screen2025-05-14T12:16:59-04:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/combination-small-molecule-inhibitors-of-ido-tdo-enzymes2023-12-21T11:56:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-rhob-antibodies-for-broad-spectrum-treatment-of-autoimmune-disease2023-12-21T11:56:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-bin1-antibodies-for-ibd2024-08-21T11:34:41-04:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-ido2-antibodies-new-treatment-for-ra-and-lupus2023-12-21T11:56:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/blood-test-to-distinguish-inflammatory-bowel-disease-from-inflammatory-bowel-syndrome2023-12-21T11:56:17-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-rabies-humab-therapy2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/diagnostics-and-vaccines-for-lyme-disease2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/new-approach-for-drug-resistant-topical-infections2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-amyloid-antibodies-curli2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/on-cell-antibody-display-from-hybridoma-cells2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-amyloid-antibodies-amyloidosis2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/anti-nmdar-antibodies2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/new-uses-of-ido-inhibitors-for-dr-and-md2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/cellcountez2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/thiox-test2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/wadsworth-fall-injury-prevention-device2023-12-21T11:56:18-05:00https://limr.mainlinehealth.org/technology-development-licensing/intellectual-property-and-other-technology/rogers-limb-support-device2025-04-23T14:48:22-04:00https://limr.mainlinehealth.org/technology-development-licensing/biotech-incubator/genomics2024-03-04T13:34:12-05:00https://limr.mainlinehealth.org/technology-development-licensing/biotech-incubator/genomics/research-services2023-11-17T15:10:35-05:00https://limr.mainlinehealth.org/technology-development-licensing/biotech-incubator/genomics/technology2023-11-17T15:09:54-05:00